- Home
- IHT vs RDHL Comparison
IHT vs RDHL Comparison
Compare IHT & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IHT | RDHL |
|---|---|---|
| Founded | 1971 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 3.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IHT | RDHL |
|---|---|---|
| Price | $1.48 | $1.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.5K | ★ 69.6K |
| Earning Date | 12-26-2025 | 09-05-2025 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,463,789.00 | ★ $9,550,000.00 |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 157.62 |
| 52 Week Low | $1.25 | $1.01 |
| 52 Week High | $4.24 | $7.44 |
Technical Indicators
Market Signals| Indicator | IHT | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 46.79 |
| Support Level | $1.25 | $1.18 |
| Resistance Level | $1.52 | $1.26 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 55.56 | 65.26 |
Price Performance
Historical ComparisonAbout IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.